Telegraph Hill Partners Mergers and Acquisitions Summary

Venture Capital Firm Profile

In the last 3 years, Telegraph Hill Partners has invested in 5 companies.

Telegraph Hill Partners’ most common sectors for investment aremedical products (54%) and life science (35%) . The Firm’s most common investment types include venture (63%) and buyout (lbo, mbo, mbi) (22%). In total, Telegraph Hill Partners has invested in 11 US states and 3 different countries. Its largest (disclosed) acquisition occurred in 2003 when it acquired Ambion for $11M.

In the last 3 years, Telegraph Hill Partners has exited 7 companies. The Firm’s most common exit type is trade sale (85%). Telegraph Hill Partners’ largest (disclosed) exit occurred in 2014 when it sold PneumRx for $475M.

Join Mergr to view Telegraph Hill Partners’ full profile and discover more middle-market private equity firms just like it.

M&A Summary

  • M&A Total Activity58
    • M&A Buy Activity32
    • M&A Sell Activity26
  • Total Sectors Invested 5
  • Total Countries Invested 3
  • M&A Buy/Sell Connections 31

Telegraph Hill Partners

360 Post Street, Suite 601,
San Francisco, California 94108
United States
(415) 765-6980
www.thpartners.net
info@thpartners.net

Telegraph Hill Partners is a specialist private equity firm focused on investing in later-stage life science, medical device, and healthcare companies. Prospective companies should be at or near profitability and demonstrate success. Other areas of interest within the healthcare sector include life science technologies, chemistry/reagent suppliers, and information management. Telegraph Hill Partners was formed in 2001 and is based in San Francisco, California.


Investment Criteria

Sectors of Interest: Healthcare Services, Information Technology, Life Science, Medical Products, Test/Measurement Equipment

Target Transaction Types: Buyout (LBO, MBO, MBI), Divestiture, Growth Capital, Secondary Buyout, Venture

Geographic Preferences: East US, Midwest US, South US, West US

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size - -
Enterprise Value - -

M&A Summary

Buy vs Sell

Year ≤ '17 '18 '19 '20 '21 '22 T
Buy (1.4/yr) # 25 2 4 1 - - 32
vol $16M $16M
Sell (1.4/yr) # 19 - 1 - 4 2 26
vol $1.4B $620M $65M $2.1B
  58

Most Recent M&A

Company Date Value Type
Specific Diagnostics, Inc. 2022-04-12 - Add-on Acquisition
San Jose, California · www.specific-dx.com
AltheaDx, Inc. 2022-04-04 65M USD Add-on Acquisition
San Diego, California · www.altheadx.com
Agena Bioscience, Inc. 2021-09-14 300M USD Add-on Acquisition
San Diego, California · www.agenabio.com
Precision NanoSystems, Inc. 2021-06-01 - Add-on Acquisition
Vancouver, British Columbia · www.precisionnanosystems.com
Akoya Biosciences, Inc. 2021-04-15 - IPO
Marlborough, Massachusetts · www.akoyabio.com
Asuragen, Inc. 2021-03-03 320M USD Add-on Acquisition
Austin, Texas · www.asuragen.com
Nivagen Pharmaceuticals, Inc. 2020-05-19 - Venture
Sacramento, California · www.nivagen.com
MedPricer.com, Inc. 2019-10-29 - Add-on Acquisition
Guilford, Connecticut · www.medpricer.com
Specific Diagnostics, Inc. 2019-09-06 - Growth Capital
San Jose, California · www.specific-dx.com
Emerging Therapy Solutions, Inc. 2019-08-21 - Venture
Bloomington, Minnesota · www.emergingtherapies.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
The Magstim Co. Ltd. 2015-01-01 Electrical Geodesics, Inc. 2020-07-02 1
Whitland, United Kingdom · www.magstim.com Eugene, Oregon · www.egi.com

M&A by Sector

Sector Current # Value All-time # Value
Medical Products 5 (50%) - 17 (53%) -
Life Science 3 (30%) - 11 (34%) 16M (100%)
Information Technology 2 (20%) - 2 (6%) -
Healthcare Services - - 1 (3%) -
Test/Measurement Equipment - - 1 (3%) -
Total 10 - 32 $16M

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 8 (80%) - 29 (91%) 16M (100%)
  California 2 (20%) - 15 (47%) 11M (65%)
  Texas - - 3 (9%) -
  Wisconsin 1 (10%) - 2 (6%) -
  Washington 1 (10%) - 2 (6%) -
  Virginia 1 (10%) - 1 (3%) -
  Utah 1 (10%) - 1 (3%) -
  Pennsylvania 1 (10%) - 1 (3%) -
  Minnesota 1 (10%) - 1 (3%) -
  Massachusetts - - 1 (3%) -
  Connecticut - - 1 (3%) -
United Kingdom 2 (20%) - 2 (6%) -
Canada - - 1 (3%) -
  British Columbia - - 1 (3%) -
Domestic 8 (80%) - 29 (91%) 16M (100%)
Cross-border 2 (20%) - 3 (9%) -
Total 10 - 32 $16M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 6 (60%) - 20 (63%) 6M (35%)
Buyout (LBO, MBO, MBI) 2 (20%) - 7 (22%) 11M (65%)
Divestiture - - 2 (6%) -
Growth Capital 1 (10%) - 2 (6%) -
Secondary Buyout 1 (10%) - 1 (3%) -
Total 10 - 32 $16M

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 13 (50%) 1.9B (90%)
Trade Sale 10 (38%) 197M (10%)
IPO 2 (8%) -
Secondary Sale 1 (4%) -
Total 26 $2.1B

Deal Values

buy # Total
< $100M 2 $16M
TOTAL $16M
Largest Ambion, Inc.
$11M (2003-05-01)
sell # Total
$100M to $1B 6 $1.8B
< $100M 6 $288M
TOTAL $2.1B
Largest PneumRx, Inc.
$475M (2014-12-04)

M&A Connections

Deals
Acquired from
Investor(s)
6%
2 (6%)
Strategic(s)
6%
2 (6%)
Exited to
Strategic(s)
88%
23 (88%)

Investor Summary

Investor Type

Venture Capital Firm

Size

Middle-Market

Established

2001

Specialist/Generalist

Specialist

Leadership

J. Matthew Mackowski

Chairman & Managing Director

Deval Lashkari

Senior Partner

Gary Curtis

Venture Partner

Thomas Raffin

Venture Partner

Robert Shepler

Managing Director

 Subscribe to unlock this and 185,509
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.4K Private Equity Firms
  • 176K M&A Transactions
  • 181K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.5K M&A Advisors
    (Investment Banks and Law Firms)
  • 66K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal